Phase 2, Multi-Center Trial of Modafinil for Methamphetamine Dependence
Public ClinicalTrials.gov record NCT00520286. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
Phase2, Double-blind, Placebo-controlled Trial of Modafinil for the Treatment of Methamphetamine Dependence
Study identification
- NCT ID
- NCT00520286
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 2
- Lead sponsor
- National Institute on Drug Abuse (NIDA)
- NIH
- Enrollment
- 210 participants
Conditions and interventions
Conditions
Interventions
- Modafinil Drug
- Placebo Drug
Drug
Eligibility (public fields only)
- Age range
- 18 Years to 65 Years
- Sex
- All
- Healthy volunteers
- Accepts healthy volunteers
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Nov 30, 2007
- Primary completion
- Nov 30, 2009
- Completion
- Feb 28, 2010
- Last update posted
- Apr 6, 2017
2007 – 2010
United States locations
- U.S. sites
- 8
- U.S. states
- 6
- U.S. cities
- 8
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| South Bay Treatment Center | San Diego | California | 92105 | — |
| Matrix Institute on Addictions | Tarzana | California | 91356 | — |
| Torrance Site | Torrance | California | 90502 | — |
| University of Colorado Health Sciences Center | Denver | Colorado | 80220 | — |
| John A. Burns School of Medicine | Honolulu | Hawaii | 96813 | — |
| Powell Chemical Dependency Center | Des Moines | Iowa | 50316 | — |
| START Research and Treatment | Kansas City | Missouri | 64131 | — |
| Salt Lake City VA Medical Center | Salt Lake City | Utah | 84148 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT00520286, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Apr 6, 2017 · Synced May 6, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT00520286 live on ClinicalTrials.gov.